Literature DB >> 26222084

Nanomedicines Targeting the Tumor Microenvironment.

Rong Tong1, Robert Langer.   

Abstract

We review recent progress in cancer nanomedicine to overcome the delivery barriers in tumor microenvironment, including the understanding in the nanomedicine delivery process, stimulus-responsive delivery, and several new strategies to normalize tumor microenvironment. The application of nanomedicine in cancer immunotherapy, a renewed cancer therapy by recent breakthrough, is also highlighted.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26222084     DOI： 10.1097/PPO.0000000000000123

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


  21 in total

1.  Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.

Authors:  Samantha M Sarett; Thomas A Werfel; Linus Lee; Meredith A Jackson; Kameron V Kilchrist; Dana Brantley-Sieders; Craig L Duvall
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 2.  Hyperthermia using nanoparticles--Promises and pitfalls.

Authors:  Punit Kaur; Maureen L Aliru; Awalpreet S Chadha; Alexzander Asea; Sunil Krishnan
Journal:  Int J Hyperthermia       Date:  2016-01-12       Impact factor: 3.914

3.  A quantitative method for screening and identifying molecular targets for nanomedicine.

Authors:  Peng Guo; Jiang Yang; Diane R Bielenberg; Deborah Dillon; David Zurakowski; Marsha A Moses; Debra T Auguste
Journal:  J Control Release       Date:  2017-03-22       Impact factor: 9.776

Review 4.  Covalent nano delivery systems for selective imaging and treatment of brain tumors.

Authors:  Julia Y Ljubimova; Tao Sun; Leila Mashouf; Alexander V Ljubimov; Liron L Israel; Vladimir A Ljubimov; Vida Falahatian; Eggehard Holler
Journal:  Adv Drug Deliv Rev       Date:  2017-06-10       Impact factor: 15.470

Review 5.  Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later.

Authors:  Gudrun C Thurner; Paul Debbage
Journal:  Histochem Cell Biol       Date:  2018-11-16       Impact factor: 4.304

Review 6.  Magnetic Nanoparticles in Cancer Therapy and Diagnosis.

Authors:  Ali Farzin; Seyed Alireza Etesami; Jacob Quint; Adnan Memic; Ali Tamayol
Journal:  Adv Healthc Mater       Date:  2020-03-20       Impact factor: 9.933

Review 7.  Tumor penetrating peptides for improved drug delivery.

Authors:  Erkki Ruoslahti
Journal:  Adv Drug Deliv Rev       Date:  2016-04-01       Impact factor: 15.470

8.  Switchable Fluorescence of Doxorubicin for Label-Free Imaging of Bioorthogonal Drug Release.

Authors:  Taha Bilal Uyar; Kui Wu; Muhan He; Irfan Khan; Maksim Royzen; Mehmet V Yigit
Journal:  ChemMedChem       Date:  2020-04-17       Impact factor: 3.466

9.  Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.

Authors:  Bing-Bing Zhang; Xiao-Jie Chen; Xu-Dong Fan; Jing-Jing Zhu; Ying-Hui Wei; Hang-Sheng Zheng; Hong-Yue Zheng; Bin-Hui Wang; Ji-Gang Piao; Fan-Zhu Li
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

Review 10.  Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.

Authors:  Zachary T Rosenkrans; Carolina A Ferreira; Dalong Ni; Weibo Cai
Journal:  Adv Healthc Mater       Date:  2020-07-21       Impact factor: 9.933
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.